Plandai Biotechnology Inc
OTC:PLPL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Plandai Biotechnology Inc
OTC:PLPL
|
US |
|
P
|
Pakistan Reinsurance Company Ltd
KAR:PAKRI
|
PK |
|
I
|
Inflection Point Acquisition Corp VI
NASDAQ:IPFX
|
US |
|
I
|
illumin Holdings Inc
F:K3S0
|
CA |
|
E
|
Elliptic Laboratories ASA
F:EIP
|
NO |
|
Latham Group Inc
NASDAQ:SWIM
|
US |
|
Thrace Plastics Holding and Commercial SA
F:TP3
|
GR |
|
E
|
EFU Life Assurance Ltd
KAR:EFUL
|
PK |
|
Microport Scientific Corp
HKEX:853
|
KY |
|
M
|
MOL Magyar Olajes Gazipari Nyrt
F:MOGB
|
HU |
|
Hemp Inc
OTC:HEMP
|
US |
|
B
|
Boryszew SA
XMUN:BOW
|
PL |
|
Cann Group Ltd
ASX:CAN
|
AU |
|
7
|
786 Investments Ltd
KAR:786
|
PK |
|
T
|
Talonx Resources Ltd
OTC:MTBMF
|
AU |
|
Q
|
Quest Holdings SA
ATHEX:QUEST
|
GR |
|
Stellar Resources Ltd
ASX:SRZ
|
AU |
Bankruptcy Probability
Plandai Biotechnology Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Plandai Biotechnology Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Plandai Biotechnology Inc
OTC:PLPL
|
44.9k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
471.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
217.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
179B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
74.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
87.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
57.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Plandai Biotechnology Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Plandai Biotechnology Inc has total debt of 1.9m USD. This includes both short-term (143.8k USD) and long-term (1.7m USD) debt.
You can find a full breakdown on its Balance Sheet.